Department of Cell and Molecular Biology
The Department of Cell and Molecular Biology at Karolinska Institutet is a nationally leading academic research center of high international standard where science comes first and foremost. CMB researchers publish regularly in the best international science journals, a result of a long-term in-house culture that promotes real impact and key breakthroughs.
CMB News
Sten Eirik Waelgaard Jacobsen new member of The Royal Swedish Academy of Sciences
Sten Eirik Waelgaard Jacobsen new member of The Royal Swedish Academy of Sciences
Sten Eirik Waelgaard Jacobsen, professor at the Department of Medicine Huddinge and the Department of Cell and Molecular Biology is a new member of The Royal Swedish Academy of Sciences.
Maria Genander have been awarded the ERC Starting Grant
Maria Genander have been awarded the ERC Starting Grant
Three researchers at Karolinska Institutet have been awarded the ERC Starting Grant 2019: Jenny Mjösberg, Maria Genander, and newly recruited Pia Dosenovic. Their projects concern inflammatory bowel disease, esophageal cancers, and HIV vaccine, respectively. In all, the ERC will support 408 early-career researchers from around the world with its prestigious starting grant this year.
András Simon appointed Head of Department at CMB
András Simon appointed Head of Department at CMB
The appointment is for a five year period and was signed by the KI Vice President Karin Dahlman-Wright starting June 1, 2019. Professor András Simon has been Acting Head of Department since January 1, 2019 succeeding Christer Höög.
Olov Andersson recipient of The Leif C. Groop award for outstanding diabetes research
Olov Andersson recipient of The Leif C. Groop award for outstanding diabetes research
Research on zebrafish that could lead to new treatments for diabetes. In his research in zebrafish, Olov Andersson strives to generate insulin-producing cells and new treatment methods for diabetes. This has led to his selection as a recipient of the Leif Groop award for outstanding research, awarded by the Lund University Diabetes Centre and sponsored by Novo Nordisk Sweden.
Study on regenerative angiogenesis in humans shows encouraging results
Study on regenerative angiogenesis in humans shows encouraging results
“I believe this an important milestone in the field of mRNA therapeutics as it starts to address many questions regarding delivery of mRNA to human tissues, the duration and level of the protein that can be expressed and the ability of the technology to have a physiologic, measurable function over a prolonged period of time”, said study co-author Dr. Kenneth Chien